Effect of Discontinuing Long-Term Spironolactone Treatment on Kidney Function Markers Among Individuals With Type 2 Diabetes and a High Risk of Kidney Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of spironolactone wash-out on albuminuria after long-term treatment in individuals with type 2 diabetes and high risk of kidney disease-An observational follow-up of the PRIORITY study
Diabetes Obes Metab 2024 Oct 28;[EPub Ahead of Print], V Wasehuus, V Rotbain Curovic, N Tofte, M Lindhardt, G Currie, C Delles, M Frimodt-Møller, H Mischak, H von der Leyen, TW Hansen, T Kümler, F Persson, P RossingFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.